Get a quick, expert overview of clinically-focused topics and
guidelines that are relevant to testing for HER2, which contributes
to approximately 25% of breast cancers today. This concise resource
by Drs. Sara Hurvitz, and Kelly McCann consolidates today's
available information on this growing topic into one convenient
resource, making it an ideal, easy-to-digest reference for
practicing and trainee oncologists. Covers the diagnosis,
treatments and targeted therapies, and management of breast cancers
that are HER2-positive. Contains sections on background and
testing, advanced disease, therapeutics, and toxicity
considerations. Includes a timely section on innovative future
therapies.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!